Sara Vesely to Research Design
This is a "connection" page, showing publications Sara Vesely has written about Research Design.
Connection Strength
0.177
-
Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher. 2006 Apr; 21(1):49-56.
Score: 0.059
-
How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc. 2004 Apr; 79(4):456-7.
Score: 0.052
-
Adolescent Pregnancy Prevention in Group Homes: Recruiting and Retention Considerations. Am J Public Health. 2018 02; 108(S1):S9-S10.
Score: 0.034
-
Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538.
Score: 0.032